Sonus Pharmaceuticals is Drug Discovery in United States that focus on drug candidates business. Founded in 1991. They cover business area such as developer, cancer therapy, treatment resistance, cancer patient, product candidate, specific protein, tumor resistance, Apatorsen, trial, bladder, lung, prostate, an investigational drug, heat shock protein, a protein, various cancer, cancer cell growth, tumor metastasis.
1991
( 33 years old in 2024 )
Drug Candidates
-
1522 217th Place South East
Suite 100
Bothell, WA 98021
United States
Private
developercancer therapytreatment resistancecancer patientproduct candidatespecific proteintumor resistanceApatorsentrialbladderlungprostatean investigational drugheat shock proteina proteinvarious cancercancer cell growthtumor metastasis
* We use standard office opening hours in near Sonus Pharmaceuticals's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Sonus Pharmaceuticals is Drug Discovery business from United States that founded in 1991 (33 years old in 2024), Sonus Pharmaceuticals business is focusing on Drug Candidates.
Sonus Pharmaceuticals headquarter office and corporate office address is located in 1522 217th Place South East Suite 100 Bothell, WA 98021 United States.
Sonus Pharmaceuticals was founded in United States.
In 2024, Sonus Pharmaceuticals is currently focus on drug candidates sector.
Above is snippet of Google Trends for "drug candidates" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Sonus Pharmaceuticals, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
